Lunit Overview
- Year Founded
-
2013
- Status
-
Public
- Employees
-
308
- Stock Symbol
-
328130
- Investments
-
1
- Share Price
-
$43.52
- (As of Thursday Closing)
Lunit General Information
Description
Lunit Inc is a medical AI software company devoted to providing AI-powered total cancer care. Its products comprise of Lunit INSIGHT CXR, AI solution for Chest x-ray; Lunit INSIGHT MMG, AI solution for Mammography; Lunit SCOPE IO, AI-Powered Biomarker for Immuno-Oncology; and Lunit SCOPE PD-L1, AI Solution for PD-L1 Expression.
Contact Information
Website
www.lunit.ioCorporate Office
- Teheran-ro 2-gil
- 15 Floor 27
- Seoul, Gangnam-gu 06241
- South Korea
Corporate Office
- Teheran-ro 2-gil
- 15 Floor 27
- Seoul, Gangnam-gu 06241
- South Korea
Lunit Timeline
Lunit Stock Performance
As of 05-Dec-2024, Lunit’s stock price is $43.52. Its current market cap is $1.25B with 28.8M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $43.52 | $42.67 | $22.81 - $74.57 | $1.25B | 28.8M | 1.3M | -$0.95 |
Lunit Financials Summary
As of 30-Sep-2024, Lunit has a trailing 12-month revenue of $29.4M.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 935,936 | 1,795,708 | 247,906 | |
| Revenue | 29,385 | 19,183 | 10,731 | 5,796 |
| EBITDA | (8,592) | (25,790) | (28,150) | (60,610) |
| Net Income | (16,331) | (28,145) | (30,274) | (64,322) |
| Total Assets | 327,941 | 207,903 | 76,928 | 78,863 |
| Total Debt | 52,099 | 15,413 | 16,073 | 790 |
Lunit Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lunit Comparisons
Industry
Financing
Details
Lunit Competitors (17)
One of Lunit’s 17 competitors is DeepWise, a Venture Capital-Backed company based in Beijing, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| DeepWise | Venture Capital-Backed | Beijing, China | ||||
| Vista.ai | Venture Capital-Backed | Palo Alto, CA | ||||
| Arterys | Formerly VC-backed | San Francisco, CA | ||||
| Aidoc | Venture Capital-Backed | Tel Aviv, Israel | ||||
| Paige | Venture Capital-Backed | New York, NY |
Lunit Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lunit Patents
Lunit Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4471791-A1 | Artificial intelligence-based medical image analysis method and system | Pending | 01-Jun-2023 | ||
| JP-2024149456-A | Method and system for comparing past and current video | Pending | 06-Apr-2023 | ||
| EP-4443384-A1 | Method and system for comparing previous image and current image | Pending | 06-Apr-2023 | ||
| US-20240249826-A1 | Method and device for generating medical information based on pathological slide image | Pending | 19-Jan-2023 | ||
| EP-4404202-A1 | Method and device for generating medical information based on pathological slide image | Pending | 19-Jan-2023 | G16H30/40 |
Lunit Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lunit Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Lunit Acquisitions (1)
Lunit’s most recent deal was a Merger/Acquisition with Volpara Health Technologies for . The deal was made on 21-May-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Volpara Health Technologies | 21-May-2024 | Merger/Acquisition | Monitoring Equipment |
Lunit Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Volpara Health Technologies | Monitoring Equipment | Wellington, New Zealand |
Lunit ESG
Risk Overview
Risk Rating
Updated April, 19, 2024
27.69 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,100
Rank
Percentile
Software & Services
Industry
of 961
Rank
Percentile
Enterprise and Infrastructure Software
Subindustry
of 379
Rank
Percentile
Lunit FAQs
-
When was Lunit founded?
Lunit was founded in 2013.
-
Where is Lunit headquartered?
Lunit is headquartered in Seoul, South Korea.
-
What is the size of Lunit?
Lunit has 308 total employees.
-
What industry is Lunit in?
Lunit’s primary industry is Decision/Risk Analysis.
-
Is Lunit a private or public company?
Lunit is a Public company.
-
What is Lunit’s stock symbol?
The ticker symbol for Lunit is 328130.
-
What is the current stock price of Lunit?
As of 05-Dec-2024 the stock price of Lunit is $43.52.
-
What is the current market cap of Lunit?
The current market capitalization of Lunit is $1.25B.
-
What is Lunit’s current revenue?
The trailing twelve month revenue for Lunit is $29.4M.
-
Who are Lunit’s competitors?
DeepWise, Vista.ai, Arterys, Aidoc, and Paige are some of the 17 competitors of Lunit.
-
What is Lunit’s annual earnings per share (EPS)?
Lunit’s EPS for 12 months was -$0.95.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
